Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Here are the three latest drugs or medical devices approved by the Food and Drug Administration this week.
The Food and Drug Administration on Thursday approved Janssen Biotech's psoriasis treatment Tremfya.
Here are seven articles published by Becker's Hospital Review this week, featuring a look into the efficacy of outcomes-based drug pricing contracts, one hospital's unique attempt to attract blood donors and a report on cybersecurity vulnerabilities in industrial robots, among…
The Food and Drug Administration on Tuesday granted full approval Amgen's biologic drug Blincyto.
The U.S. House of Representatives on Wednesday passed a bill to reauthorize the Food and Drug Administration's user fee program, reports Regulatory Focus.
Outcomes-based drug pricing, which sets drug prices based on how much they improve patients' health, is gaining steam in the U.S. healthcare system. However, many industry stakeholders are skeptical of the methodology, which has few proven benefits, according to a…
The QuintilesIMS Institute recently conducted a study on drug spending composition and evolution in five countries — France, Germany, Japan, U.K. and the United States.
Chicago-based LifeSource, one of the largest blood suppliers in Illinois, says this summer's blood shortage is the worst they've ever seen, according to WGN9.
David C. Dvorak on Tuesday resigned from his post as president and CEO of Zimmer Biomet.
The U.S. Food and Drug Administration on July 5 issued a warning letter to Vista Pharmaceuticals, citing "significant violations of current good manufacturing practice regulations for finished pharmaceuticals."